Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome

Dermatol Pract Concept. 2023 Jul 1;13(3):e2023178. doi: 10.5826/dpc.1303a178.
No abstract available

Publication types

  • Letter